Bronnen:
- Keystone EC, Taylor PC, Tanaka Y, et al. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study. Ann Rheum Dis. 2017 Aug 10.
Bronnen:
jan 2022 | Osteoporose
dec 2021 | Osteoporose
sep 2021 | Osteoporose
sep 2021 | Osteoporose
aug 2021 | Osteoporose
jul 2021 | Eczeem, Huidinfecties, Psoriasis
dec 2020 | Osteoporose
dec 2020 | Osteoporose
nov 2020